ArticleArchives of gynecology and obstetrics2025
Effects of sperm DNA fragmentation on embryo morphokinetic parameters and laboratory outcomes in women of different ages during intracytoplasmic sperm treatment cycles.
Article in Archives of gynecology and obstetrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Rho-kinase inhibition reduces DNA fragmentation in human sperm cryopreservation.Asian journal of andrology · 2026Article
- Impact of semen quality on the risk of direct cleavage in human embryos.Journal of assisted reproduction and genetics · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundWhether SDF (sperm DNA fragmentation) influences embryo development and the clinical outcomes of assisted reproductive technology (ART) cycles remains controversial. Oocytes derived from women of different ages have varying abilities to repair SDF.
objectiveThis study aimed to explore the correlation between SDF and the morphokinetic parameters of embryos during intracytoplasmic sperm injection (ICSI) treatment cycles with consideration of the different ages of female patients. MATERIALS AND
methodsA total of 301 ICSI cycles between April 2022 and December 2023 were analyzed in this retrospective study. Cycles were categorized into two groups according to female age: the older group (females aged ≥ 35 years) and the younger group (females aged < 35 years). Moreover, each age group was further divided into low- and high- sperm DNA fragmentation index (DFI) subgroups. The morphokinetic parameters of embryo development and the laboratory outcomes were compared between the two DFI subgroups within each age category.
resultsIn the younger group, there were no differences between the two DFI groups in terms of the rate of usable blastocyst formation on Day 5; time to 2, 3, 4, 5, 6, 7, and 8 cells; or timing of blastulation. However, in the older group, the rate of usable blastocyst formation on Day 5 was significantly greater in the low DFI group than in the high DFI group (35.6% vs. 23.4%, p = 0.030). Although the times to reach 2, 3, 4, 5, 6, 7, and 8 cells were similar across the two DFI groups, the time to blastulation (tB) was significantly shorter in the low DFI group than in the high DFI group (106.5 ± 9.0 h vs. 111.1 ± 10.3 h, p = 0.013).
conclusionSDF could adversely affect the rate of usable blastocyst formation on Day 5 and delay the formation of usable blastocysts only when oocytes were derived from women of advanced maternal age. These results may indicate that oocytes derived from younger females have a greater capacity to repair SDF than those from women of advanced maternal age.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.